Evidence map›Paper›PMID 30227752›Full record

ArticleHealth promotion practice2018

Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs.

Lauren L Knight, Katherine Wagner, Yuridia Leyva, Veronica R Bruce, Kirsten A M White, Yvonne S Talamantes, Brittany Price, Kimberly Page, Martha L Carvour

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health promotion practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. International journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lauren L Knight1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Katherine Wagner1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Yuridia Leyva1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Veronica R Bruce1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Kirsten A M White1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Yvonne S Talamantes1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Brittany Price1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Kimberly Page1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Martha L Carvour1 University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0000-0003-2295-5062
University of New Mexico · US

Funding

UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
Acute Hepatitis C Infection in Young InjectorsR01DA016017 · NIDA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAGE, KIMBERLY · 2002 to 2018
$14.0M
Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New MexicoU18PS004568 · PS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAGE, KIMBERLY · 2014 to 2016
$900k
ACL HHS U18PS004568NCATS NIH HHS UL1 TR001449NCHHSTP CDC HHS U18 PS004568NIDA NIH HHS R01 DA016017
6 · The paper itself

Abstract

introductionYoung adults who inject drugs and live in rural communities are at high risk for hepatitis C virus (HCV) infection. Recent changes in HCV treatment must be communicated within these communities to improve access to care and reduce HCV transmission.

methodsField workers in the ¡VÁLE! Hepatitis Treatment and Integrated Prevention Services study identified frequently asked questions (FAQs) posed by young-adult participants at high risk for HCV during screening and educational sessions. From 2016 to 2018, 183 young adults (44.3% women; 85.8% Latino/a) younger than 30 years who inject drugs and reside in Rio Arriba or Doña Ana counties in New Mexico were enrolled. The research team compiled deidentified questions during field enrollments.

resultsFAQs were reviewed and categorized into four major domains, including risk/prevention, screening, treatment, and reinfection. FAQs were addressed by a team of medical and public health professionals, using the most current research and recommendations.

conclusionsThese FAQs address important gaps in HCV knowledge among young adults who are at high risk for infection. The FAQs also highlight the importance of risk reduction counseling provided by frontline public health providers as well as access to safe and effective HCV treatments for young adults who inject drugs.

Indexed as

Hispanic or LatinoAdultAntiviral AgentsCounselingFemaleHealth PromotionHealth Services AccessibilityHepatitis CHumansMaleMass ScreeningNew MexicoPublic HealthRural PopulationSubstance Abuse, IntravenousYoung AdultAntiviral Agentsaccess to health careepidemiologyhealth educationminority healthrural health

Identifiers

PMID30227752
PMCPMC6436913
OpenAlexW2891253507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.